Patheon to Present on “Cleaning Validation: Science, Risk and Novel Approaches to Testing”
The company will host a complimentary webinar on Tuesday, June 4, 2013 at 11 a.m. Eastern Standard Time.
(PRWEB) May 23, 2013
Patheon Inc., a leading provider of contract development and manufacturing services to the global pharmaceutical industry, will host a complimentary webinar on “Cleaning Validation: Science, Risk and Novel Approaches to Testing” on Tuesday, June 4, 2013 at 11 a.m. Eastern Standard Time.
All pharmaceutical manufacturers are required to comply with regulations for cleaning validation. Many companies have incorporated their historical practices with limited scientific underpinning and little evaluation of risk. Some companies have chosen to avoid the debate entirely by using expensive, disposable systems exclusively. Using the latitude available in current good manufacturing practices for the 21st century, scientific data evaluation, and risk-based approaches can streamline the process. By developing sound and defensible programs with rapid and specific testing, cleaning validation can be efficiently and effectively implemented.
Led by Andrew Walsh, Industry Professor at Stevens Institute of Technology, and Geoff Carr, Ph.D., Director, Analytical Development at Patheon, the webinar will:
- Introduce the science-driven risk-based guide for cleaning validation being developed by the International Society for Pharmaceutical Engineering (ISPE)
- Discuss practical considerations for implementing cleaning validation programs
- Highlight the speed and efficiency benefits of liquid chromatography-mass spectrometry (LC-MS) for development and execution of cleaning test methods
To register for the event visit the company´s website at http://www.patheon.com/Knowledge-Library/Events.aspx.
Patheon Inc. (TSX: PTI) is a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry for a full array of solid and sterile dosage forms. Through the company´s recent acquisition of Banner Pharmacaps — a market leader in soft gelatin capsule technology — Patheon now also includes a proprietary products and technology business.
Patheon provides the highest quality products and services to approximately 300 of the world’s leading pharmaceutical and biotechnology companies. The company’s integrated network consists of 18 locations, including 14 commercial contract manufacturing facilities and 12 development centers across North America and Europe. Patheon enables customer products to be launched with confidence anywhere in the world. For more information visit http://www.patheon.com.
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2013/5/prweb10759766.htm